The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
News Medical on MSN1d
GLP-1 drug exenatide shows no benefit for Parkinson's in new studyThe GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in ...
Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...
News Medical on MSN6d
Alzheimer’s and Parkinson’s linked to aging brain’s failing waste disposalNew research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...
Propranolol reduces Parkinson’s tremor and motor cortex activity, suggesting a new therapeutic approach beyond stress ...
Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback